Novavax Inc (NVAX)
$46.30
1.64 (3.67%)
NVAX Stock Quote Delayed 30 Minutes
Previous Close
$46.30
Market Cap
17.67B
PE Ratio
-75.90
EPS
-0.61
Volume (Avg. Vol.)
8.08M
Day's Range
45.26 - 50.49
52-Week Range
3.54 - 61.50
Dividend & Yield
N/A (N/A)
NVAX Stock Predictions, Articles, and Novavax Inc News
4 Top Stock Trades for Wednesday: UBER, ACB, NVAX, DKNG
Uber, Novavax, DraftKings and Aurora Cannabis were our top stock trades for Wednesday. Let's have a look at what the charts say.
Novavax News: NVAX Stock Skyrockets 79% on COVID-19 Vaccine Funding
Novavax (NVAX) news for Tuesday concerning funding for a vaccine to stop the novel coronavirus has NVAX stock rocketing higher.
Novavax News: NVAX Stock Surges 14% as Human Trial for Coronavirus Vaccine Nears
Novavax (NVAX) news for Wednesday concerning a trial for a vaccine to treat the coronavirus from China has NVAX stock flying high.
How We “Flipped” a Beaten-Down Company for 126% Gains
Investors began buying up NVAX shares in anticipation of the Phase 3 clinical trial announcement. We wound up with a 130% gain on the trade.
Novavax Earnings: NVAX Stock Soars 8% on Strong Q4 Revenue Beat
Novavax (NVAX) earnings for the vaccine company's fiscal fourth quarter of 2019 have NVAX stock heading higher after-hours Wednesday.
Stock Market Today: Turnaround Tuesday; Tesla’s Big Milestone
Tesla made its one-millionth car, while Delta expects to save $2 billion in fuel costs. Here's the stock market today.
Stock Market Today: Coronavirus Stokes Fear; Uber Stock Rallies
Boeing shares tanked on more negative reports, while Uber rallied on an asset sale. Here's what happened in the stock market today.
Novavax News: NVAX Stock Skyrockets 52% on Mystery China Virus
Novavax (NVAX) news for Tuesday concerning the spread of a virus in China has NVAX stock heading higher as more investors pick up the stock.
Novavax News: Why NVAX Stock Is Shooting Higher Today
Novavax news for Thursday concerning an accelerated approval pathway for one of the company's drugs has NVAX stock soaring higher.
Novavax News: Why NVAX Stock Is Plunging Today
Novavax news concerning the results from the company's recent trail of its drug ResVax has NVAX stock falling on Thursday.
Novavax Stock Is a Cautionary Tale for Speculators
Novavax stock is plunging on Thursday after failing a Phase 3 study. That sets up a breakdown instead of a breakout in NVAX stock.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
A
